Pieris Pharmaceuticals Inc

NASDAQ:PIRS  
3.46
-0.04 (-1.14%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)249.34M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$3.98 Million
Adjusted EPS-$0.29
See more estimates
10-Day MA$3.69
50-Day MA$4.58
200-Day MA$3.57
See more pivots

Pieris Pharmaceuticals Inc Stock, NASDAQ:PIRS

255 State Street, 9th floor, Boston, Massachusetts 02109
United States of America
Phone: +1.857.246.8998
Number of Employees: 123

Description

Pieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of Anticalin-based drugs. Its pipeline includes immuno-oncology, respiratory, and anemia and other disease areas. The company was founded by Claus Schalper and Arne Skerra in 2001 and is headquartered in Boston, MA.